CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population
- 1 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 16 (9), 637-645
- https://doi.org/10.1097/01.fpc.0000230411.89973.1b
Abstract
To study the correlation between CYP3A5 genotype and quinine 3-hydroxylation in black Tanzanian and Swedish Caucasians as well as to investigate the interethnic differences in CYP3A activity between the two populations. Tanzanian (n=144) and Swedish (n=136) healthy study participants were given a single oral 250 mg dose of quinine hydrochloride and a 16-h post-dose blood sample was collected. The metabolic ratio of quinine/3-hydroxyquinine was determined in plasma by high-performance liquid chromatography. All the participants were genotyped for the known mutations of CYP3A5, which are relevant for the respective population. Correlation between quinine metabolic ratio and CYP3A5 genotype as well as the interethnic difference in CYP3A activity between the two populations was studied. Tanzanians had significantly higher (PConclusions Clear interethnic differences were observed in the activity of CYP3A between Tanzanians and Swedes. A significant association is noted between CYP3A5 genotype and quinine 3-hydroxylation in Tanzanians, indicating a significant contribution of CYP3A5 to total 3A activity. The CYP3A4 catalyzed hydroxylation of quinine (two low CYP3A5 expression alleles) was lower in Tanzanians than in Swedes.Keywords
This publication has 46 references indexed in Scilit:
- Metabolism and elimination of quinine in healthy volunteersEuropean Journal of Clinical Pharmacology, 2003
- Randomized Comparison of Artesunate and Quinine in the Treatment of Severe Falciparum MalariaClinical Infectious Diseases, 2003
- Enzyme Kinetics for the Formation of 3-Hydroxyquinine and Three New Metabolites of Quinine in Vitro; 3-Hydroxylation by CYP3A4 is Indeed the Major Metabolic PathwayDrug Metabolism and Disposition, 2002
- Simultaneous determination of quinine and four metabolites in plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- In vivo modulation of CYP enzymes by quinidine and rifampinClinical Pharmacology & Therapeutics, 2000
- Induction of Drug Metabolising EnzymesClinical Pharmacokinetics, 2000
- Evidence for involvement of human CYP3A in the 3‐hydroxylation of quinineBritish Journal of Clinical Pharmacology, 1997
- Metabolism of Quinine in Man: Identification of a Major Metabolite, and Effects of Smoking and Rifampicin PretreatmentJournal of Pharmacy and Pharmacology, 1995
- Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.British Journal of Clinical Pharmacology, 1995
- Antimalarial pharmacokinetics and treatment regimens.British Journal of Clinical Pharmacology, 1992